Alan Pollack

23.8k total citations · 5 hit papers
465 papers, 17.4k citations indexed

About

Alan Pollack is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alan Pollack has authored 465 papers receiving a total of 17.4k indexed citations (citations by other indexed papers that have themselves been cited), including 335 papers in Pulmonary and Respiratory Medicine, 154 papers in Radiation and 93 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alan Pollack's work include Prostate Cancer Diagnosis and Treatment (261 papers), Prostate Cancer Treatment and Research (250 papers) and Advanced Radiotherapy Techniques (154 papers). Alan Pollack is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (261 papers), Prostate Cancer Treatment and Research (250 papers) and Advanced Radiotherapy Techniques (154 papers). Alan Pollack collaborates with scholars based in United States, Canada and Israel. Alan Pollack's co-authors include Gunar K. Zagars, Deborah A. Kuban, Andrew C. von Eschenbach, George Starkschall, Eric M. Horwitz, Eugene Huang, Alexandra L. Hanlon, Isaac Rosen, Mark K. Buyyounouski and Lei Dong and has published in prestigious journals such as Science, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Alan Pollack

455 papers receiving 16.8k citations

Hit Papers

Prostate cancer radiation... 2002 2026 2010 2018 2002 2007 2007 2013 2016 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
    2002 1.1k citations Alan Pollack, Gunar K. Zagars et al. International Journal of Radiation Oncology*Biology*Physics profile →
  2. Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
    2007 938 citations Deborah A. Kuban, Alan Pollack et al. International Journal of Radiation Oncology*Biology*Physics profile →
  3. Predicting the Outcome of Salvage Radiation Therapy for Recurrent Prostate Cancer After Radical Prostatectomy
    2007 633 citations Howard M. Sandler, Jeffrey D. Forman et al. profile →
  4. Randomized Trial of Hypofractionated External-Beam Radiotherapy for Prostate Cancer
    2013 340 citations Alan Pollack, Eric M. Horwitz et al. profile →
  5. Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy
    2016 229 citations Matthew C. Abramowitz, Alan Pollack et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Alan Pollack 12.7k 6.3k 3.2k 2.2k 2.1k 465 17.4k
Gerald E. Hanks 13.9k 1.1× 6.6k 1.0× 3.3k 1.0× 3.9k 1.8× 2.2k 1.1× 393 19.4k
Mack Roach 12.7k 1.0× 7.1k 1.1× 3.8k 1.2× 2.3k 1.1× 1.7k 0.8× 374 16.2k
David P. Dearnaley 11.3k 0.9× 4.6k 0.7× 5.0k 1.6× 4.3k 1.9× 3.7k 1.7× 416 18.4k
Steven A. Leibel 11.1k 0.9× 8.5k 1.3× 6.0k 1.9× 2.8k 1.3× 1.7k 0.8× 208 17.1k
Howard D. Thames 8.6k 0.7× 5.0k 0.8× 5.3k 1.7× 2.9k 1.3× 3.2k 1.5× 298 16.4k
Herman D. Suit 10.7k 0.8× 3.6k 0.6× 3.6k 1.1× 2.8k 1.3× 5.4k 2.6× 324 17.7k
Mitchell S. Anscher 6.6k 0.5× 3.4k 0.5× 5.0k 1.6× 2.5k 1.1× 2.4k 1.2× 268 12.8k
Stephanie E. Combs 6.3k 0.5× 2.8k 0.4× 3.8k 1.2× 1.9k 0.9× 2.2k 1.0× 503 13.5k
Guy Storme 6.0k 0.5× 4.1k 0.6× 2.9k 0.9× 1.7k 0.8× 2.2k 1.0× 255 10.8k
Michael J. Zeléfsky 21.5k 1.7× 12.5k 2.0× 6.2k 2.0× 6.6k 3.0× 4.0k 1.9× 544 29.3k

Countries citing papers authored by Alan Pollack

Since Specialization
Citations

This map shows the geographic impact of Alan Pollack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Pollack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Pollack more than expected).

Fields of papers citing papers by Alan Pollack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Pollack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Pollack. The network helps show where Alan Pollack may publish in the future.

Co-authorship network of co-authors of Alan Pollack

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Pollack. A scholar is included among the top collaborators of Alan Pollack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Pollack. Alan Pollack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Algohary, Ahmad, Evangelia I. Zacharaki, Sandra M. Gaston, et al.. (2023). Uncovering prostate cancer aggressiveness signal in T2‐weighted MRI through a three‐reference tissues normalization technique. NMR in Biomedicine. 37(3). e5069–e5069. 2 indexed citations
3.
Goldgof, Dmitry B., Lawrence Hall, Joseph Johnson, et al.. (2023). Classifying Malignancy in Prostate Glandular Structures from Biopsy Scans with Deep Learning. Cancers. 15(8). 2335–2335. 2 indexed citations
4.
Stoyanova, Radka, Olmo Zavala‐Romero, Deukwoo Kwon, et al.. (2023). Clinical-Genomic Risk Group Classification of Suspicious Lesions on Prostate Multiparametric-MRI. Cancers. 15(21). 5240–5240. 3 indexed citations
5.
Alshalalfa, Mohammed, Idalid Franco, Randy Vince, et al.. (2022). Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer and Prostatic Diseases. 25(2). 366–369. 13 indexed citations
6.
Udayakumar, Thirupandiyur S., Anis Ahmad, Wensi Tao, et al.. (2020). Radiation Attenuates Prostate Tumor Antiviral Responses to Vesicular Stomatitis Virus Containing IFNβ, Resulting in Pronounced Antitumor Systemic Immune Responses. Molecular Cancer Research. 18(8). 1232–1243. 20 indexed citations
7.
Stoyanova, Radka, Alan Dal Pra, Matthew C. Abramowitz, et al.. (2020). Post-Treatment Biopsy Positivity In Prostate Cancer Patients Undergoing MpMRI-Targeted Radiation Dose Escalation. International Journal of Radiation Oncology*Biology*Physics. 108(3). e870–e870. 1 indexed citations
8.
Eade, Thomas, Ananya Choudhury, Alan Pollack, et al.. (2018). Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study. International Journal of Radiation Oncology*Biology*Physics. 101(4). 957–963. 6 indexed citations
9.
Parra, Nestor A., Alan Pollack, Matthew C. Abramowitz, et al.. (2017). Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness. Frontiers in Oncology. 7. 259–259. 15 indexed citations
10.
Ackerstaff, Ellen, Warren D. Foltz, Carl Fisher, et al.. (2017). Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI. Scientific Reports. 7(1). 9746–9746. 50 indexed citations
11.
Udayakumar, Thirupandiyur S., Radka Stoyanova, Mohammed M. Shareef, et al.. (2016). Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor Activity. Molecular Cancer Therapeutics. 15(6). 1353–1363. 13 indexed citations
12.
Johnson, Skyler B., Pamela R. Soulos, Timothy D. Shafman, et al.. (2016). Patient-Reported Quality of Life After Stereotactic Body Radiation Therapy Versus Moderate Hypofractionation for Clinically Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 96(2). E242–E242. 1 indexed citations
13.
Pollack, Alan, Kyounghwa Bae, Li‐Yan Khor, et al.. (2009). The Importance of Protein Kinase A in Prostate Cancer: Relationship to Patient Outcome in Radiation Therapy Oncology Group Trial 92-02. Clinical Cancer Research. 15(17). 5478–5484. 24 indexed citations
14.
Diefenbach, Michael A., Nihal Mohamed, Eric M. Horwitz, & Alan Pollack. (2008). Longitudinal associations among quality of life and its predictors in patients treated for prostate cancer: The moderating role of age. Psychology Health & Medicine. 13(2). 146–161. 26 indexed citations
15.
Hanlon, A.L., et al.. (2004). Identification of groups at risk for distant metastasis and death in men with a rising PSA after radiotherapy for prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(1). S233–S234. 1 indexed citations
16.
Konski, André, Deborah Watkins Bruner, Alexandra L. Hanlon, et al.. (2004). Intensity modulated radiation therapy (IMRT) is a cost-effective treatment for intermediate risk prostate cancer. International Journal of Radiation Oncology*Biology*Physics. 60(1). S144–S144. 5 indexed citations
17.
Campbell, Timothy, John C. Blasko, E. David Crawford, et al.. (2001). Clinical staging of prostate cancer: Reproducibility and clarification of issues. International Journal of Cancer. 96(3). 198–209. 19 indexed citations
18.
19.
Pollack, Alan, Scott P. Lankford, Gunar K. Zagars, & R. Joseph Babaian. (1996). Prostate specific antigen density as a prognostic factor for patients with prostate carcinoma treated with radiotherapy. Cancer. 77(8). 1515–1523. 17 indexed citations
20.
Pollack, Alan & Gaetano Ciancio. (1990). Chapter 3 Cell Cycle Phase-Specific Analysis of Cell Viability Using Hoechst 33342 and Propidium Iodide after Ethanol Preservation. Methods in cell biology. 33. 19–24. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerald E. Hanks Breakdown of academic impact, for papers by Mack Roach Breakdown of academic impact, for papers by David P. Dearnaley Breakdown of academic impact, for papers by Steven A. Leibel Breakdown of academic impact, for papers by Howard D. Thames Breakdown of academic impact, for papers by Herman D. Suit Breakdown of academic impact, for papers by Mitchell S. Anscher Breakdown of academic impact, for papers by Stephanie E. Combs Breakdown of academic impact, for papers by Guy Storme Breakdown of academic impact, for papers by Michael J. Zeléfsky
Rankless by CCL
2026